Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solid-phase synthesis of a pepticinnamin E library.

Michael Thutewohl1, Herbert Waldmann

  • 1Max-Planck-Institut für molekulare Physiologie, Abt. Chemische Biologie, Otto-Hahn-Str. 11, D-44227, Organische Chemie, Universität Dortmund, Dortmund und Fachbereich 3, Germany

Bioorganic & Medicinal Chemistry
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Synthesis, and Biological Evaluation of Pseudo-Natural Products Inspired by Aryloctahydroindole Alkaloids.

ChemMedChem·2026
Same author

Covalent modification of a glutamic acid inspired by HaloTag technology.

Nature communications·2026
Same author

Targeting a Glutamic Acid in PDEδ with Fluoromethyl-Aryl Electrophiles Impairs K-Ras Signaling.

Journal of medicinal chemistry·2026
Same author

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

Nature chemistry·2026
Same author

Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2.

ACS chemical biology·2025
Same author

Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders.

Angewandte Chemie (International ed. in English)·2025

Researchers synthesized 51 analogues of pepticinnamin E, a farnesyltransferase inhibitor. This study focused on creating diverse chemical structures to explore structure-activity relationships for potential therapeutic applications.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Enzyme Inhibition

Background:

  • Pepticinnamin E is a natural product identified as a bisubstrate inhibitor of farnesyltransferase.
  • Farnesyltransferase is a key enzyme implicated in various cellular processes and diseases.

Purpose of the Study:

  • To synthesize a library of pepticinnamin E analogues by modifying eight structural parameters.
  • To explore the structure-activity relationships of pepticinnamin E derivatives.
  • To identify novel inhibitors of farnesyltransferase.

Main Methods:

  • Parallel synthesis of 51 analogues on a polymeric support.
  • Utilized three distinct synthetic routes.
  • Employed 6-11 step syntheses for analogue generation.

Related Experiment Videos

Main Results:

  • Successfully synthesized a library of 51 pepticinnamin E analogues.
  • Achieved overall yields ranging from 3% to 63%.
  • All synthesized compounds demonstrated high purity (>90%).

Conclusions:

  • The synthetic strategy enabled the creation of a diverse compound library based on pepticinnamin E.
  • The synthesized analogues provide a valuable resource for further investigation into farnesyltransferase inhibition.
  • This work facilitates the discovery of new therapeutic agents targeting farnesyltransferase.